Bosulif: Indications, Dosage, Precautions, Adverse Effects
Россия
  • Россия
  • Украина

Manufacture: Pfizer Inc.
Country: Canada
Condition: Chronic Myelogenous Leukemia
Class: BCR-ABL tyrosine kinase inhibitors
Form: Tablets
Ingredients: bosutinib, microcrystalline cellulose, croscarmellose sodium, poloxamer, povidone, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide yellow (for 100 mg tablet) and iron oxide red (for 500 mg tablet)